Frequency, Behavior, and Prognostic Implications of Antimitochondrial Antibodies in Type 1 Autoimmune Hepatitis
Authors:
- Aldo J. Montano-LozaAldo J. Montano-Loza
- Herschel A. CarpenterHCHerschel A. Carpenter
- Albert J. CzajaACAlbert J. Czaja
- 1 October 2008
- journal article
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 42 (9) , 1047-1053
Abstract
Antimitochondrial antibodies (AMA) can occur in autoimmune hepatitis, but their durability and prognostic significance are uncertain. Determine the frequency, behavior, and prognostic implications of AMA in type 1 autoimmune hepatitis. One hundred thirty patients were tested for AMA by the same enzyme-linked immunosorbent assay at accession and during 123±9 months of observation (mean, 6±0.2 determinations/patient). Findings were correlated with clinical and histologic features and treatment outcomes. Twenty-four patients (18%) had AMA, including 17 who had the antibodies at accession (71%) and 7 who developed them during follow-up (29%). AMA persisted in 13 patients (54%) who were tested on 5±1 occasions during 141±33 months. Cholestatic histologic features occurred as commonly in patients with and without AMA at presentation (18% vs. 10%, P=0.4). AMA disappeared in 4 patients, and they developed in 7 patients after 34±7 months. Late expression of antibodies was not associated with a higher frequency of cholestatic histologic changes than continued seronegativity (14% vs. 9%, P=0.5). Remission (83% vs. 76%, P=0.4) and treatment failure (8% vs. 11%, P>0.9) occurred as commonly in both groups. AMA can appear and disappear. They do not identify a subgroup that requires different treatment or that evolves quickly into a cholestatic syndrome.Keywords
This publication has 50 references indexed in Scilit:
- HLA Class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitisJournal of Hepatology, 2006
- Development of autoimmune hepatitis in patients with typical primary biliary cirrhosisHepatology, 2006
- Occurrence of Autoimmune Hepatitis During the Course of Primary Biliary Cirrhosis: Report of Two CasesDigestive Diseases and Sciences, 2006
- Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: A retrospective analysisHepatology, 2002
- International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitisJournal of Hepatology, 1999
- Frequency and Significance of Antibodies to Actin in Type 1 Autoimmune HepatitisHepatology, 1996
- Autoantibodies to M2 mitochondrial autoantigens in normal human sera by immunofluorescence and novel assaysJournal of Gastroenterology and Hepatology, 1996
- Detection of Autoantibodies to Recombinant Mitochondrial Proteins in Patients with Primary Biliary CirrhosisNew England Journal of Medicine, 1989
- Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitisDigestive Diseases and Sciences, 1986
- Effects of meals and interruption of enterohepatic circulation on flow, lipid composition, and cholesterol saturation of bile in man after cholecystectomyDigestive Diseases and Sciences, 1975